<DOC>
	<DOCNO>NCT00913393</DOCNO>
	<brief_summary>The purpose study evaluate effect FG-3019 diabetic kidney disease diabetic nephropathy .</brief_summary>
	<brief_title>Study FG-3019 Subjects With Type 2 DM KD ACEi and/or ARB Therapy</brief_title>
	<detailed_description>The primary objective study assess effect FG-3019 proteinuria assess urinary albumin/creatinine ratio ( ACR ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Key 1 . Signed write informed consent 2 . Males females 1875 year age , inclusive 3 . Diagnosis type 2 diabetes mellitus accord American Diabetes Association ( ADA ) criteria 4 . 24hour urinary ACR 2003000 mg/g , inclusive , two occasion screen least 2 day apart 5 . Estimated glomerular filtration rate ( eGFR ) ( MDRD equation ) &gt; 20 mL/min/1.73 m2 6 . Mean systolic blood pressure less equal 150 mmHg mean diastolic blood pressure less equal 95 mmHg 7 . Receiving ACEi and/or ARB therapy unchanged dose minimum trial dosage least 3 month prior first Screening visit willing maintain dos throughout treatment period Key 1 . Females pregnant breast feed 2 . Organ transplant recipient , history dialysis , know nondiabetic renal disease benign cysts anatomical variant 3 . History New York Heart Association class III/IV heart failure 4 . Screening electrocardiogram show acute and/or clinically significant finding include limited ST depression 5 . History follow event within 3 month prior Screening : coronary artery bypass graft , cerebrovascular accident , myocardial infarction , transient ischemic attack , unstable angina , uncontrolled cardiac arrhythmia , atrial fibrillation , percutaneous coronary intervention , vascular stent placement 6 . History anaphylactic systemic allergic reaction human , humanize , chimeric , murine monoclonal antibody 7 . Aspartate aminotransferase ( AST ) and/or alanine aminotransferase ( ALT ) &gt; 2.5 time upper limit normal ; direct bilirubin upper limit normal , &gt; 2.5 time upper limit normal case document Gilbert 's syndrome 8 . Hemoglobin &lt; 10 g/dL 9 . Hemoglobin A1c ( HbA1c ) &gt; 9 % 10 . Low density lipoprotein ( LDL ) &gt; 130 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>